Article
Alemtuzumab Reduces Preexisting MS Disability
In addition to slowing disability accumulation, alemtuzumab improves preexisting disability in patients with relapsing-remitting multiple...
Sponsored Supplement
Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Risk: Where Are We Today?
Article
Using CHIMPS for type A dissection in a high-risk patient
Chimney and sandwich grafts facilitated hybrid repair of type A aortic dissection in a high-risk patient.
Article
Newborns with CHD have reduced cerebral oxygen delivery
Using a newer form of MRI to investigate oxygen levels in newborns with congenital heart disease, researchers in Canada reported that these...
Article
Time to rethink bioprosthetic valve guidelines?
Recent findings on the incidence and pathophysiology of bioprosthetic valve thrombosis require revisiting existing guidelines against routine...
Article
Disease severity, QOL outcome measures need standardizing in atopic dermatitis research
The number of outcome measures used to assess disease severity and quality of life in atopic dermatitis studies has risen in recent years, but an...
Article
Vitamin D as an Add-On Therapy May Improve MRI Outcomes in MS
LONDON—High-dose vitamin D as an add-on therapy may improve MRI outcomes in patients with relapsing-remitting multiple sclerosis (MS), according...
Article
Early Administration of Sertraline May Prevent Onset of Depression Following TBI
Sertraline may help to prevent the onset of depressive disorders after a traumatic brain injury (TBI), according to data published online ahead of...
Article
‘Stepping’ up to a better way to teach robotic lobectomy
Robotic lobectomy can be successfully taught by dividing the procedure into a series of surgical maneuvers or steps.
Article
A tricky interplay, indeed
Bone disease in patients with kidney disease is indeed a tricky interplay, as the article by Nyman et al (J Fam Pract. 2016;65:606-612)...